Literature DB >> 19348708

Recent advances in the genetics of amyotrophic lateral sclerosis.

Paul N Valdmanis1, Hussein Daoud, Patrick A Dion, Guy A Rouleau.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disorder with a low survival rate beyond 5 years from symptom onset. Although the genes that cause most cases of ALS are still unknown, several important genetic discoveries have been made recently that will bring substantial insight into some of the mechanisms involved in ALS. Mutations in two genes with related functions were recently reported in patients with familial ALS: the FUS/TLS gene at the ALS6 locus on chromosome 16 and the TARDBP gene at the ALS10 locus on chromosome 1. In addition, the first wave of genomewide association studies in ALS has been published. While these studies clearly show that there is no definitive and common highly penetrant allele that causes ALS, some interesting candidate genes emerged from these studies. The findings help to better delineate the types of genes and genetic variants that are involved in ALS and provide substantial material for future research.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19348708     DOI: 10.1007/s11910-009-0030-9

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  67 in total

1.  DPP6 gene variability confers increased risk of developing sporadic amyotrophic lateral sclerosis in Italian patients.

Authors:  R Del Bo; S Ghezzi; S Corti; D Santoro; A Prelle; M Mancuso; G Siciliano; C Briani; L Murri; N Bresolin; G P Comi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-09       Impact factor: 10.154

2.  A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2.

Authors:  S Hadano; C K Hand; H Osuga; Y Yanagisawa; A Otomo; R S Devon; N Miyamoto; J Showguchi-Miyata; Y Okada; R Singaraja; D A Figlewicz; T Kwiatkowski; B A Hosler; T Sagie; J Skaug; J Nasir; R H Brown; S W Scherer; G A Rouleau; M R Hayden; J E Ikeda
Journal:  Nat Genet       Date:  2001-10       Impact factor: 38.330

3.  ITPR2 as a susceptibility gene in sporadic amyotrophic lateral sclerosis: a genome-wide association study.

Authors:  Michael A van Es; Paul W Van Vught; Hylke M Blauw; Lude Franke; Christiaan G Saris; Peter M Andersen; Ludo Van Den Bosch; Sonja W de Jong; Ruben van 't Slot; Anna Birve; Robin Lemmens; Vianney de Jong; Frank Baas; Helenius J Schelhaas; Kristel Sleegers; Christine Van Broeckhoven; John H J Wokke; Cisca Wijmenga; Wim Robberecht; Jan H Veldink; Roel A Ophoff; Leonard H van den Berg
Journal:  Lancet Neurol       Date:  2007-10       Impact factor: 44.182

4.  Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations.

Authors:  Ian R A Mackenzie; Eileen H Bigio; Paul G Ince; Felix Geser; Manuela Neumann; Nigel J Cairns; Linda K Kwong; Mark S Forman; John Ravits; Heather Stewart; Andrew Eisen; Leo McClusky; Hans A Kretzschmar; Camelia M Monoranu; J Robin Highley; Janine Kirby; Teepu Siddique; Pamela J Shaw; Virginia M-Y Lee; John Q Trojanowski
Journal:  Ann Neurol       Date:  2007-05       Impact factor: 10.422

5.  Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Authors:  Masato Hasegawa; Tetsuaki Arai; Takashi Nonaka; Fuyuki Kametani; Mari Yoshida; Yoshio Hashizume; Thomas G Beach; Emanuele Buratti; Francisco Baralle; Mitsuya Morita; Imaharu Nakano; Tatsuro Oda; Kuniaki Tsuchiya; Haruhiko Akiyama
Journal:  Ann Neurol       Date:  2008-07       Impact factor: 10.422

6.  Paraoxonase promoter and intronic variants modify risk of sporadic amyotrophic lateral sclerosis.

Authors:  Simon Cronin; Matthew J Greenway; Jochen H M Prehn; Orla Hardiman
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-09       Impact factor: 10.154

7.  New VAPB deletion variant and exclusion of VAPB mutations in familial ALS.

Authors:  J E Landers; A L Leclerc; L Shi; A Virkud; T Cho; M M Maxwell; A F Henry; M Polak; J D Glass; T J Kwiatkowski; A Al-Chalabi; C E Shaw; P N Leigh; I Rodriguez-Leyza; D McKenna-Yasek; P C Sapp; R H Brown
Journal:  Neurology       Date:  2008-03-05       Impact factor: 9.910

8.  Variants of the elongator protein 3 (ELP3) gene are associated with motor neuron degeneration.

Authors:  Claire L Simpson; Robin Lemmens; Katarzyna Miskiewicz; Wendy J Broom; Valerie K Hansen; Paul W J van Vught; John E Landers; Peter Sapp; Ludo Van Den Bosch; Joanne Knight; Benjamin M Neale; Martin R Turner; Jan H Veldink; Roel A Ophoff; Vineeta B Tripathi; Ana Beleza; Meera N Shah; Petroula Proitsi; Annelies Van Hoecke; Peter Carmeliet; H Robert Horvitz; P Nigel Leigh; Christopher E Shaw; Leonard H van den Berg; Pak C Sham; John F Powell; Patrik Verstreken; Robert H Brown; Wim Robberecht; Ammar Al-Chalabi
Journal:  Hum Mol Genet       Date:  2008-11-07       Impact factor: 6.150

9.  Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data.

Authors:  Jennifer C Schymick; Sonja W Scholz; Hon-Chung Fung; Angela Britton; Sampath Arepalli; J Raphael Gibbs; Federica Lombardo; Mar Matarin; Dalia Kasperaviciute; Dena G Hernandez; Cynthia Crews; Lucie Bruijn; Jeffrey Rothstein; Gabriele Mora; Gabriella Restagno; Adriano Chiò; Andrew Singleton; John Hardy; Bryan J Traynor
Journal:  Lancet Neurol       Date:  2007-04       Impact factor: 44.182

10.  Familial amyotrophic lateral sclerosis with frontotemporal dementia is linked to a locus on chromosome 9p13.2-21.3.

Authors:  Caroline Vance; Ammar Al-Chalabi; Deborah Ruddy; Bradley N Smith; Xun Hu; Jemeen Sreedharan; Teepu Siddique; H Jurgen Schelhaas; Benno Kusters; Dirk Troost; Frank Baas; Vianney de Jong; Christopher E Shaw
Journal:  Brain       Date:  2006-02-22       Impact factor: 13.501

View more
  39 in total

Review 1.  How can we improve clinical trials in amyotrophic lateral sclerosis?

Authors:  Paul H Gordon; Vincent Meininger
Journal:  Nat Rev Neurol       Date:  2011-09-27       Impact factor: 42.937

2.  Homozygous SMN2 deletion is a protective factor in the Swedish ALS population.

Authors:  Philippe Corcia; Caroline Ingre; Helene Blasco; Rayomand Press; Julien Praline; Catherine Antar; Charlotte Veyrat-Durebex; Yves-Olivier Guettard; William Camu; Peter M Andersen; Patrick Vourc'h; Christian R Andres
Journal:  Eur J Hum Genet       Date:  2012-01-25       Impact factor: 4.246

Review 3.  Extending the knowledge in histochemistry and cell biology.

Authors:  Wolfgang-Moritz Heupel; Detlev Drenckhahn
Journal:  Histochem Cell Biol       Date:  2009-11-28       Impact factor: 4.304

Review 4.  Amyotrophic Lateral Sclerosis: An update for 2013 Clinical Features, Pathophysiology, Management and Therapeutic Trials.

Authors:  Paul H Gordon
Journal:  Aging Dis       Date:  2013-10-01       Impact factor: 6.745

Review 5.  Need for a paradigm shift in therapeutic approaches to CNS injury.

Authors:  Bharath Wootla; Aleksandar Denic; Arthur E Warrington; Moses Rodriguez
Journal:  Expert Rev Neurother       Date:  2012-04       Impact factor: 4.618

6.  A de novo missense mutation of the FUS gene in a "true" sporadic ALS case.

Authors:  Adriano Chiò; Andrea Calvo; Cristina Moglia; Irene Ossola; Maura Brunetti; Luca Sbaiz; Shiao-lin Lai; Yevgeniya Abramzon; Bryan J Traynor; Gabriella Restagno
Journal:  Neurobiol Aging       Date:  2010-07-03       Impact factor: 4.673

Review 7.  TDP-43/FUS in motor neuron disease: Complexity and challenges.

Authors:  Erika N Guerrero; Haibo Wang; Joy Mitra; Pavana M Hegde; Sara E Stowell; Nicole F Liachko; Brian C Kraemer; Ralph M Garruto; K S Rao; Muralidhar L Hegde
Journal:  Prog Neurobiol       Date:  2016-09-28       Impact factor: 11.685

8.  A novel small molecule HSP90 inhibitor, NXD30001, differentially induces heat shock proteins in nervous tissue in culture and in vivo.

Authors:  Jieun R C Cha; Kyle J H St Louis; Miranda L Tradewell; Benoit J Gentil; Sandra Minotti; Zahara M Jaffer; Ruihong Chen; Allan E Rubenstein; Heather D Durham
Journal:  Cell Stress Chaperones       Date:  2013-10-03       Impact factor: 3.667

9.  Neurotrophic growth factors for the treatment of amyotrophic lateral sclerosis: where do we stand?

Authors:  Alexandre Henriques; Claudia Pitzer; Armin Schneider
Journal:  Front Neurosci       Date:  2010-06-11       Impact factor: 4.677

10.  Age-related motor neuron degeneration in DNA repair-deficient Ercc1 mice.

Authors:  Monique C de Waard; Ingrid van der Pluijm; Nils Zuiderveen Borgesius; Laura H Comley; Elize D Haasdijk; Yvonne Rijksen; Yanto Ridwan; Gerben Zondag; Jan H J Hoeijmakers; Ype Elgersma; Thomas H Gillingwater; Dick Jaarsma
Journal:  Acta Neuropathol       Date:  2010-07-04       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.